Schrodinger Inc
Change company Symbol lookup
Select an option...
SDGR Schrodinger Inc
SEDG Solaredge Technologies Inc
KO Coca-Cola Co
VIRX Viracta Therapeutics Inc
ROP Roper Technologies Inc
TJX TJX Companies Inc
LICT LICT Corp
ARLP Alliance Resource Partners LP
BOOM DMC Global Inc
ABTI Alterola Biotech Inc
Go

Health Care : Health Care Technology | Small Cap Blend
Company profile

Schrodinger, Inc. has developed a physics-based software platform, which enables discovery of molecules for drug development and materials applications. The software platform is used by biopharmaceutical and industrial companies, academic institutions and government laboratories around the world. The Company also leverages its software platform to advance collaborative programs and its own pipeline of therapeutics to address unmet medical needs. The Company operates through two segments: software and drug discovery. The software segment is focused on selling its software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on building a portfolio of preclinical and clinical programs, internally and through collaborations, which has advanced to various stages of discovery and development. The Company’s pipeline of drug discovery programs include MALT1, CDC7, Wee1, and SOS1/KRAS.

Closing Price
$16.48
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Heavy Day)
Volume:
697,934

10-day average volume:
515,171
697,934

Display:

Providers:

UpdateCancel
6 providers
November 21, 2022
Schrodinger to Present at Piper Sandler 34th Annual Healthcare Conference

Schrodinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare...(BusinessWire)

November 18, 2022
Schrodinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrodinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today reported that on November 15, 2022, the company granted non-statutory stock options to purchase an...(BusinessWire)

November 07, 2022
Schrodinger to Present at Jefferies 13th Annual London Healthcare Conference

Schrodinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies 13th Annual London...(BusinessWire)

November 03, 2022
Schrodinger Reports Third Quarter 2022 Financial Results

--Full-Year 2022 Revenue Guidance Range Narrowed, with Mix Shifting Toward Drug Discovery --Phase 1 Clinical Trial of MALT1 Inhibitor, SGR-1505, Open for Patient Enrollment --New Preclinical Data for CDC7 Inhibitor, SDGR-2921, to Be Presented at...(BusinessWire)

Schrodinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting

Schrodinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that new preclinical data on its CDC7 inhibitor, SGR-2921, will be presented during a...(BusinessWire)

October 20, 2022
Schrodinger to Announce Third Quarter 2022 Financial Results on November 3

Schrodinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its third quarter 2022 financial results on Thursday, November 3, 2022, after the financial markets...(BusinessWire)

October 06, 2022
Schrodinger Hosts Platform Day

--Outlines Opportunities for Future Innovation and Long-Term Value Creation --Announces Drug Discovery Collaboration with Lilly; Schrodinger to Receive Upfront Payment and Up to $425 million in Milestone Payments Plus Royalties (BusinessWire)

September 20, 2022
Schrodinger to Host Platform Day on October 6, 2022

Schrodinger (Nasdaq: SDGR), whose physics-based software platform is transforming the way therapeutics and materials are discovered, today announced that the company will host Platform Day in New York City on Thursday, October 6, 2022, beginning at...(BusinessWire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.